June 22, 2015
Powerful supercomputers around the country continue to push advances in critical areas, such as cancer research. One of the latest such success stories comes ou Read more…
August 25, 2014
MD Anderson Cancer Center researchers are relying on a powerful supercomputer to develop a dosing protocol for an MRI-guided radiation therapy for cancer care, Read more…
November 7, 2012
NYU researchers use TACC and XSEDE supercomputers to model the effect of carcinogenic compounds on DNA. Read more…
February 29, 2012
As part of its Powering the Possible charitable program, Dell is providing the secure cloud-based IT infrastructure to support the world's first personalized medicine clinical trial for pediatric cancer. The research is being conducted by the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC) at the Van Andel Research Institute (VARI) and supported by The Translational Genomics Research Institute (Tgen). Read more…
Did you miss out on Supercomputing 2017? Did you attend, but were stuck in meetings the whole time without an opportunity to walk the show floor and see what new announcements were being made? HPCwire's got you covered, we visited some of the hottest booths in the exhibit hall and spoke with their top executives to get the scoop on the latest solutions, partnerships, and product announcements.
From mismatches between compute and storage capabilities to colossal data volumes, data storage presents a number of challenges for scientific research. And as silos pop up and challenges expand, the pace of research often suffers.
As genomic data becomes ubiquitous, infrastructure bottlenecks for life sciences organizations are narrowing. But speedy analysis and real-time decision making don't have to remain out of reach: modern end-to-end systems are emerging as flexible solutions for a competitive edge.
© HPCwire. All Rights Reserved. A Tabor Communications Publication
Reproduction in whole or in part in any form or medium without express written permission of Tabor Communications, Inc. is prohibited.